Virginie Lleu
Directeur/Membre du Conseil chez MEDINCELL S.A.
Fortune : 696 323 $ au 30/04/2024
Profil
Virginie Lleu has founded L3S Partnership in 2010 where she holds the title of Managing Director.
Currently, she holds the position of Chairman at Fondation Fondamental, Director at YSOPIA Biosciences SA, and Member-Supervisory Board at MedinCell SA. In the past, she worked as Director-Human Resources at Jouveinal and as Senior Consultant at Pact & Partners International ApS.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
MEDINCELL SA
0,16% | 31/03/2023 | 45 350 ( 0,16% ) | 696 323 $ | 30/04/2024 |
Postes actifs de Virginie Lleu
| Sociétés | Poste | Début |
|---|---|---|
| MEDINCELL S.A. | Directeur/Membre du Conseil | 25/05/2016 |
YSOPIA Biosciences SA
 YSOPIA Biosciences SA BiotechnologyHealth Technology LNC Therapeutics SA operates as a research and development company that designs and develops medical food formulas. It's develop therapeutic solutions for metabolic and cardiometabolic disorders. The firm also designs and develops formulas for obesity and pre-diabetes sickness. Its products include Stablor, Bariamed, and Fertimed. It encompass serious game, patient community, and support tools: BariaSpoon and BariaFork. The company was founded by Jérôme Théron and Claude Vincent on October 29, 2010 and is headquartered in Bordeaux, France. | Directeur/Membre du Conseil | - |
| L3S Partnership | Directeur Général | 01/10/2010 |
Fondation Fondamental
 Fondation Fondamental Medical/Nursing ServicesHealth Services Fondation Fondamental is a research organization that focuses on mental illnesses. The private company is based in Creteil, France. The French company's mission is to advance research in this field and help reduce the impact of mental illnesses. | Président | - |
Anciens postes connus de Virginie Lleu
| Sociétés | Poste | Fin |
|---|---|---|
| Pact & Partners International ApS | Corporate Officer/Principal | - |
Jouveinal
 Jouveinal Chemicals: SpecialtyProcess Industries Part of Pfizer Inc., Jouveinal is a French company that manufactures and markets pharmaceuticals, consumer health care products, and confectionery. The company is located in France. Jouveinal was acquired by Warner-Lambert Co. on May 21, 1997. | Responsable des Ressources Humaines | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MEDINCELL S.A. | Health Technology |
| Entreprise privées | 5 |
|---|---|
YSOPIA Biosciences SA
YSOPIA Biosciences SA BiotechnologyHealth Technology LNC Therapeutics SA operates as a research and development company that designs and develops medical food formulas. It's develop therapeutic solutions for metabolic and cardiometabolic disorders. The firm also designs and develops formulas for obesity and pre-diabetes sickness. Its products include Stablor, Bariamed, and Fertimed. It encompass serious game, patient community, and support tools: BariaSpoon and BariaFork. The company was founded by Jérôme Théron and Claude Vincent on October 29, 2010 and is headquartered in Bordeaux, France. | Health Technology |
Jouveinal
Jouveinal Chemicals: SpecialtyProcess Industries Part of Pfizer Inc., Jouveinal is a French company that manufactures and markets pharmaceuticals, consumer health care products, and confectionery. The company is located in France. Jouveinal was acquired by Warner-Lambert Co. on May 21, 1997. | Process Industries |
| Pact & Partners International ApS | |
| L3S Partnership | |
Fondation Fondamental
Fondation Fondamental Medical/Nursing ServicesHealth Services Fondation Fondamental is a research organization that focuses on mental illnesses. The private company is based in Creteil, France. The French company's mission is to advance research in this field and help reduce the impact of mental illnesses. | Health Services |
